
Biotech Firms Accelerate 2025 IPO Surge Amid Regulatory Overhauls
The Brewing Biotech Capital Revolution What if 2025 becomes the banner year that reshapes biotech financing for decades? Across laboratories from Boston to San Diego, a palpable urgency grips emerging life sciences